Journal of Clinical Psychopharmacology · 2004 · 57 citations · 18 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyMicronutrient DeficiencyPsychoneuroimmunologyVitamin DVitamin PhysiologyAbnormal Involuntary Movement ScaleAntioxidant VitaminsParallel Study DesignsPlacebo ComparatorsPlacebo Effect In TreatmentSuperoxide Dismutase FunctionTardive Dyskinesia TreatmentTardive Dystonia
Free radicals may be involved in the pathogenesis of tardive dyskinesia (TD). Vitamin E, a free radical scavenger, has been reported to improve symptoms of TD. The present study was designed to replicate this finding in a group of Chinese patients with TD, and to examine the effect of vitamin E treatment on blood superoxide dismutase (SOD), a critical enzyme in the detoxification of free radicals. Forty-one inpatients with TD completed a double-blind, placebo-controlled, parallel-group study of vitamin E. Twenty-two of the patients were randomly assigned to receive a fixed dose of 1200 IU/d vitamin E, and 19 were assigned to a placebo for 12 weeks. Patients were assessed primarily using the Abnormal Involuntary Movement Scale (AIMS) at baseline, weeks 6 and 12. Blood SOD levels were measured by radioimmunometric assay before and after treatment. The results showed that the reduction in AIMS score from baseline was significantly higher with vitamin E treatment compared with placebo (45.9% vs. 4.3%). Blood SOD levels were significantly increased after treatment with vitamin E (P = 0.001), but no change with placebo treatment (P < 0.05). These results support earlier findings of the efficacy of vitamin E in the treatment of TD. Moreover, the efficacy of vitamin E may be due to its ability to increase SOD level, which may reduce oxidative injure in tardive dyskinesia.
18
Para-amino-salicylic acid in pulmonary tuberculosis.
Treatment of tardive dyskinesia with vitamin E
M.F. Egan, Thomas M. Hyde, Gregory W. Albers et al. · American Journal of Psychiatry · 1992 · 150 citations
Medicine, Neurology, Pharmacotherapy +13